Moreover, different hyperactive mTOR mutants, which were identified previously in cancer patients12 and which induced robust mTORC1 signaling in H460par cells, sensitized to 2DG/DCA-induced apoptosis and led to impaired clonogenic growth in the presence of 2DG/DCA (Fig. 2j–l). Here, MTOR is linked to cancer.